ADVANCED POLYMER SYSTEMS ACQUIRING PREMIER OTC DRUG/TOILETRY DISTRIBUTOR
This article was originally published in The Tan Sheet
ADVANCED POLYMER SYSTEMS ACQUIRING PREMIER OTC DRUG/TOILETRY DISTRIBUTOR for approximately 450,000 shares of common stock, the company announced March 18. APS' stock has been trading in the $ 7-$ 9 range this year, making the purchase price between $ 3 and $ 4 mil. The company expects the acquisition to be completed within a month and plans to operate Premier as a wholly owned subsidiary. Premier, which had 1992 sales of about $ 7.5 mil., is the exclusive U.S. marketer of three Johnson & Johnson products -- Sundown and Baby Block sunscreens and Take Off make-up remover squares. The company distributes the products under long-term marketing agreements renewable in 1996. Premier also sells APS' two consumer products, EveryStep shoe and foot deodorant and Exact acne medication, which use APS' Microsponge controlled-release delivery system. APS had 1992 sales of $ 7.3 mil. "Premier brings to APS solid sales, marketing and distribution capabilities for OTC products, a key step we have envisioned for the the development of our company," APS stated, adding that "Premier's market position in the sun protection field should be of long-term value to APS." APS is seeking FDA approval for ProZone, a sunscreen product containing genetically engineered melanin. ProZone is in Phase III clinical trials. APS expects to complete clinical testing by the end of 1993. The company also has a tretinoin acne medication in Phase III trials. Both products use the Microsponge technology. Premier's headquarters will remain in Greenwich, Conn., where it leases a 48,068 square foot facility. The six-year-old firm was founded by Advanced Polymer Systems President and Chairman John Meakem before he joined APS; he is a major shareholder in Premier. The firm has 12 employees and is headed by Robert Albus, who will continue as president following the acquisition.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Sign in to continue reading.
Need a specific report?
1000+ reports available
New to Pink Sheet?
Start a free trial today!
Register for our free email digests: